Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antineutrophil Cytoplasmic Antibody-Associated Vasculitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05965284
What this trial is testing

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

Who this might be right for
ANCA-associated VasculitisMaintenance Therapy
Chinese SLE Treatment And Research Group 40
Not applicableStudy completedNCT04413149
What this trial is testing

Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.

Who this might be right for
Interstitial Lung DiseaseAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Peking Union Medical College Hospital 80
Testing effectiveness (Phase 2)UnknownNCT01633476
What this trial is testing

CMV Modulation of the Immune System in ANCA-associated Vasculitis

Who this might be right for
ANCA Associated VasculitisCMV Infection
Professor Lorraine Harper 38
Not applicableLooking for participantsNCT07010250
What this trial is testing

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Who this might be right for
ANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more
Assistance Publique - Hôpitaux de Paris 146
Not applicableEnded earlyNCT01586858
What this trial is testing

Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study

Who this might be right for
Granulomatosis With PolyangiitisMicroscopic Polyangiitis
Johns Hopkins University 67
Not applicableLooking for participantsNCT07150000
What this trial is testing

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

Who this might be right for
Rheumatic DiseasesRheumatoid Arthritis (RA)Giant Cell Arteritis (GCA)+10 more
University of Bonn 120
Not applicableStudy completedNCT03430388
What this trial is testing

Yellow Fever Vaccine in Patients With Rheumatic Diseases

Who this might be right for
Systemic LupusRheumatoid ArthritisSpondyloarthritis+8 more
University of Sao Paulo General Hospital 600
Very early researchNot Yet RecruitingNCT07596680
What this trial is testing

CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases

Who this might be right for
SLE - Systemic Lupus ErythematosusSystemic SclerosisANCA Associated Vasculitis+2 more
Nanjing Bioheng Biotech Co., Ltd. 30
Large-scale testing (Phase 3)Looking for participantsNCT06512883
What this trial is testing

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilia Syndrome (HES)
AstraZeneca 14
Testing effectiveness (Phase 2)UnknownNCT00751517
What this trial is testing

Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides

Who this might be right for
Wegener's GranulomatosisChurg-Strauss SyndromeMicroscopic Polyangiitis+1 more
University of Parma
Testing effectiveness (Phase 2)Study completedNCT03895801
What this trial is testing

Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

Who this might be right for
Granulomatosis With Polyangiitis (GPA)Microscopic Polyangiitis (MPA)
InflaRx GmbH 57
Early research (Phase 1)Looking for participantsNCT07236801
What this trial is testing

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic SclerosisSjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT07800871
What this trial is testing

FT839 in Autoimmune Diseases

Who this might be right for
ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Rheumatoid Arthritis (RA)+2 more
Fate Therapeutics 446
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Not applicableLooking for participantsNCT03004326
What this trial is testing

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Who this might be right for
Cryoglobulinemic Vasculitis (CV)Drug-induced VasculitisEosinophilic Granulomatosis With Polyangiitis (EGPA)+7 more
Peter Merkel 50
Testing effectiveness (Phase 2)Looking for participantsNCT06828042
What this trial is testing

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSystemic Sclerosis (SSc)Sjogren Syndrome+3 more
Peking University Third Hospital 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06388941
What this trial is testing

Iptacopan in Patients With ANCA Associated Vasculitis

Who this might be right for
Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Ended earlyNCT03712345
What this trial is testing

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA

Who this might be right for
Granulomatosis With Polyangiitis (GPA)Microscopic Polyangiitis (MPA)
InflaRx GmbH 20
Testing effectiveness (Phase 2)Ended earlyNCT00482066
What this trial is testing

Abatacept in ANCA Associated Vasculitis

Who this might be right for
ANCA-associated Vasculitis
Imperial College London 7
Not applicableStudy completedNCT00001473
What this trial is testing

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

Who this might be right for
VasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 100
Next Page